Syner-G BioPharma Group
Myke Scoggins has a wealth of experience in the pharmaceutical and biotech industries. Myke currently holds the position of Senior Director of CMC Development and Project Management at Syner-G BioPharma Group, starting in April 2021. Prior to this, they worked at Recro Gainesville LLC, where they held the roles of Director of Product Development from September 2018 to April 2021, and Process Development Manager from May 2017 to September 2018.
Before joining Recro Gainesville LLC, Myke Scoggins was a Senior Scientist at Osmotica Pharmaceutical Corp. from September 2016 to May 2017. Myke also worked as a Senior Pharmaceutical Scientist at Micromeritics Instrument Corporation from August 2014 to September 2016.
Earlier in their career, Myke Scoggins held the position of Lab Manager / Pharmaceutical Scientist at Micromeritics Pharmaceutical Services from June 2013 to July 2014. Myke served as the Associate Director of Microbial Assays/Chemistry at WuXi AppTec from November 2012 to June 2013.
Prior to that, they worked as a Senior Process Engineer and Laboratory Operations Leader for GLP Programs at Chemtura from April 2012 to November 2012. Myke was also a Research Scientist II at Georgia Institute of Technology from March 2011 to April 2012.
Myke Scoggins started their career at Abbott Products, Inc. / Solvay Pharmaceuticals, where they held the position of Scientist from June 2003 to January 2011. Myke also worked as a Manager of Manufacturing Liaison at First Horizon Pharmaceutical from April 2002 to June 2003.
Myke Scoggins has a PhD in Pharmaceutical Sciences from Mercer University. Prior to that, they obtained a Bachelor's degree in Microbiology from The University of Georgia. The specific start and end years for each education are not provided.
This person is not in the org chart
This person is not in any offices
Syner-G BioPharma Group
Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT. We call this CMC 360™. We also provide medical writing services, with expertise in authoring a variety of regulatory documents across a wide range of therapeutic areas and in all phases of development. Our regulatory affairs services include the development and implementation of global regulatory strategic plans, regulatory agency meeting support, and electronic submissions to regulatory authorities around the world. We have the skill set and experience to guide your prime asset through any development challenges and along the ever-changing maze of regulatory filing pathways, to a position of full compliance, and high quality. Our expertise spans small molecules, peptides, oligonucleotides, biologics, monoclonal antibodies, antibody-drug conjugates, and cell and gene therapy products.